Skip to main content
$0.125 (0.00%)

High

$0.13

Low

$0.12

Trades

20

Turnover

$48,049

Volume

400,697
30 June 2023 at 3:57pm
If you were already registered, log in here.

[ARTICLE] Markets Live: Financials plummet on euro concerns

A news article has been posted about Cynata Therapeutics on the AFR. The article was published around , on 1 January 1970 at 10:00am.

O:8:"stdClass":10:{s:4:"kind";s:19:"customsearch#result";s:5:"title";s:49:"Markets Live: Financials plummet on euro concerns";s:9:"htmlTitle";s:49:"Markets Live: Financials plummet on euro concerns";s:4:"link";s:98:"https://www.afr.com/markets/business/markets-live-futures-plummet-on-euro-concerns-20180530-h10pz4";s:11:"displayLink";s:11:"www.afr.com";s:7:"snippet";s:160:"May 29, 2018 ... In small caps, Cynata Therapeutics conducted a $5.2 million share placement to global equities manager Fidelity International, increasing ...";s:11:"htmlSnippet";s:182:"May 29, 2018 <b>...</b> In small caps, <b>Cynata Therapeutics</b> conducted a $5.2 million share placement to <br> global equities manager Fidelity International, increasing&nbsp;...";s:12:"formattedUrl";s:86:"https://www.afr.com/.../markets-live-futures-plummet-on-euro-concerns- 20180530-h10pz4";s:16:"htmlFormattedUrl";s:86:"https://www.afr.com/.../markets-live-futures-plummet-on-euro-concerns- 20180530-h10pz4";s:7:"pagemap";O:8:"stdClass":3:{s:13:"cse_thumbnail";a:1:{i:0;O:8:"stdClass":3:{s:3:"src";s:112:"https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcT-vzIbIbWhHaAX2VLvX_qi31aEt8qPbvVHpLNImoTee7ADMBEQiZGva6jz";s:5:"width";s:3:"299";s:6:"height";s:3:"168";}}s:8:"metatags";a:1:{i:0;O:8:"stdClass":34:{s:16:"apple-itunes-app";s:9:"524599864";s:8:"og:image";s:337:"https://static.ffx.io/images/$width_800%2C$height_450/t_crop_fill/e_sharpen:25%2Cq_85%2Cf_auto/t_afr_live_social_wm/l_text:SuecaNano-Semibold.ttf_28:%20FROM%20%2Cg_south_west%2Cy_84%2Cx_355%2Cco_rgb:111111//l_text:SuecaNano-Semibold.ttf_56:%202018%20%2Cg_south_west%2Cy_25%2Cx_330%2Cco_rgb:111111/fdbb50f34ee728f97de6d619eb3143870359efef";s:22:"article:published_time";s:20:"2018-05-29T22:12:00Z";s:14:"og:image:width";s:4:"1200";s:12:"twitter:card";s:19:"summary_large_image";s:12:"og:site_name";s:27:"Australian Financial Review";s:14:"parsely-author";s:15:"William McInnes";s:14:"og:description";s:140:"Shares are firmly below the 6000-point mark after the Italian political crisis escalated, reviving fears the monetary union is under threat.";s:16:"parsely-metadata";s:36:"{"id":"h10pz4","type":"liveArticle"}";s:17:"article:publisher";s:40:"https://www.facebook.com/financialreview";s:19:"og:image:secure_url";s:337:"https://static.ffx.io/images/$width_800%2C$height_450/t_crop_fill/e_sharpen:25%2Cq_85%2Cf_auto/t_afr_live_social_wm/l_text:SuecaNano-Semibold.ttf_28:%20FROM%20%2Cg_south_west%2Cy_84%2Cx_355%2Cco_rgb:111111//l_text:SuecaNano-Semibold.ttf_56:%202018%20%2Cg_south_west%2Cy_25%2Cx_330%2Cco_rgb:111111/fdbb50f34ee728f97de6d619eb3143870359efef";s:25:"parsely-network-canonical";s:98:"https://www.afr.com/markets/business/markets-live-futures-plummet-on-euro-concerns-20180530-h10pz4";s:12:"parsely-type";s:11:"NewsArticle";s:12:"twitter:site";s:16:"@FinancialReview";s:21:"article:modified_time";s:23:"2018-05-30T06:33:41.08Z";s:13:"news_keywords";s:58:"ASX, sharemarket, investing, investments, equities, shares";s:12:"parsely-link";s:98:"https://www.afr.com/markets/business/markets-live-futures-plummet-on-euro-concerns-20180530-h10pz4";s:17:"parsely-image-url";s:337:"https://static.ffx.io/images/$width_800%2C$height_450/t_crop_fill/e_sharpen:25%2Cq_85%2Cf_auto/t_afr_live_social_wm/l_text:SuecaNano-Semibold.ttf_28:%20FROM%20%2Cg_south_west%2Cy_84%2Cx_355%2Cco_rgb:111111//l_text:SuecaNano-Semibold.ttf_56:%202018%20%2Cg_south_west%2Cy_25%2Cx_330%2Cco_rgb:111111/fdbb50f34ee728f97de6d619eb3143870359efef";s:15:"parsely-section";s:8:"business";s:7:"og:type";s:7:"article";s:15:"article:section";s:8:"business";s:13:"twitter:title";s:49:"Markets Live: Financials plummet on euro concerns";s:8:"og:title";s:49:"Markets Live: Financials plummet on euro concerns";s:15:"og:image:height";s:3:"628";s:8:"fb:pages";s:15:"150910108292573";s:13:"parsely-title";s:49:"Markets Live: Financials plummet on euro concerns";s:11:"article:tag";s:12:"Markets Live";s:16:"parsely-pub-date";s:23:"2018-05-30T06:33:41.08Z";s:17:"twitter:image:src";s:337:"https://static.ffx.io/images/$width_800%2C$height_450/t_crop_fill/e_sharpen:25%2Cq_85%2Cf_auto/t_afr_live_social_wm/l_text:SuecaNano-Semibold.ttf_28:%20FROM%20%2Cg_south_west%2Cy_84%2Cx_355%2Cco_rgb:111111//l_text:SuecaNano-Semibold.ttf_56:%202018%20%2Cg_south_west%2Cy_25%2Cx_330%2Cco_rgb:111111/fdbb50f34ee728f97de6d619eb3143870359efef";s:9:"fb:app_id";s:15:"112905165500100";s:12:"parsely-tags";s:12:"MARKETS LIVE";s:8:"viewport";s:37:"width=device-width, initial-scale=1.0";s:19:"twitter:description";s:140:"Shares are firmly below the 6000-point mark after the Italian political crisis escalated, reviving fears the monetary union is under threat.";s:6:"og:url";s:98:"https://www.afr.com/markets/business/markets-live-futures-plummet-on-euro-concerns-20180530-h10pz4";}}s:9:"cse_image";a:1:{i:0;O:8:"stdClass":1:{s:3:"src";s:194:"https://static.ffx.io/images/$zoom_0.5826%2C$multiply_0.2833%2C$ratio_1.776846%2C$width_1059%2C$x_215%2C$y_120/t_crop_custom/e_sharpen:25%2Cq_85%2Cf_auto/ad32955bb55e9152935c1569491d01c38534fbc8";}}}}

Read Article
Recent Articles about ASX:CYP
29-Oct Appendix 3B - Proposed issue of securities - AFR

company-announcements.afr.com

1-Oct Notification of cessation of securities - CYP - 11 Sep 2026

company-announcements.afr.com

28-Sep CYP:ASX Announcement - Appendix 4G - 28 Sep 2026

company-announcements.afr.com

29-Aug Actinogen Appendix 4E and 2026 digital annual report - AFR

company-announcements.afr.com

26-Aug Acrux Ltd (ACR:ASX) - AFR

company-announcements.afr.com

25-Aug Acrux Ltd (ACR:ASX) - AFR

company-announcements.afr.com

3-Aug CYP:ASX Announcement - Expected Timing of Clinical Trial Results

company-announcements.afr.com

4-Jul Form 603 - Corporations Act 2001 Section 671B - AFR

company-announcements.afr.com

3-Jul Form 605 Notice of ceasing to be a substantial holder - AFR

company-announcements.afr.com

3-Jul CYP-001 Graft Versus Host Disease Trial: Primary Evaluation Results

company-announcements.afr.com

Tracked

Find all articles about Cynata Therapeutics, including others on the AFR, on the media page.

If you were already registered, log in here.

If you were already registered, log in here.

If you were already registered, log in here.